WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H328207
CAS#: 2062-77-3 (HCl)
Description: Trifluperidol, also known as Trifluperidol HCl and R-2498, is a dopamine D2-receptor antagonist used to treat schizophrenia.
Hodoodo Cat#: H328207
Name: Trifluperidol HCl
CAS#: 2062-77-3 (HCl)
Chemical Formula: C22H24ClF4NO2
Exact Mass: 0.00
Molecular Weight: 445.883
Elemental Analysis: C, 59.26; H, 5.43; Cl, 7.95; F, 17.04; N, 3.14; O, 7.18
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Related CAS #: 749-13-3 (free base) 2062-77-3 (HCl)
Synonym: Trifluperidol; Trifluperidol hydrochloride; R-2498; R 2498; R2498
IUPAC/Chemical Name: 1-(4-fluorophenyl)-4-(4-hydroxy-4-(3-(trifluoromethyl)phenyl)piperidin-1-yl)butan-1-one hydrochloride
InChi Key: VYGQXRZAHIZHQV-UHFFFAOYSA-N
InChi Code: InChI=1S/C22H23F4NO2.ClH/c23-19-8-6-16(7-9-19)20(28)5-2-12-27-13-10-21(29,11-14-27)17-3-1-4-18(15-17)22(24,25)26;/h1,3-4,6-9,15,29H,2,5,10-14H2;1H
SMILES Code: O=C(C1=CC=C(F)C=C1)CCCN2CCC(C3=CC=CC(C(F)(F)F)=C3)(O)CC2.[H]Cl
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info: Related CAS# 749-13-3 (Trifluperidol) 2062-77-3 (Trifluperidol Hydrochloride)
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 445.88 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Szenohradszky J, Gibiszer PK, Pórszász J Jr, Gács E. Effects of beta adrenergic blocking drugs and trifluperidol on intestinal motility and splanchnic nerve activity in cats. Acta Chir Hung. 1983;24(4):307-21. PubMed PMID: 6670434.
2: Fortes ZB. The effect of trifluperidol on the contractile response of guinea-pig taenia coli to acetylcholine, histamine, potassium and calcium. Gen Pharmacol. 1984;15(5):423-5. PubMed PMID: 6510679.
3: Kowalski J, Labuzek K, Herman ZS. Flupentixol and trifluperidol reduce interleukin-1 beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Pol J Pharmacol. 2004 Sep-Oct;56(5):563-70. PubMed PMID: 15591644.
4: Kowalski J, Labuzek K, Herman ZS. Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-alpha and nitric oxide by rat microglial cells. Neurochem Int. 2003 Jul;43(2):173-8. PubMed PMID: 12620286.
5: Coughenour LL, Cordon JJ. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes. J Pharmacol Exp Ther. 1997 Feb;280(2):584-92. PubMed PMID: 9023267.
6: Singh SP, Giridhar C, Avasthi A. Neuroleptic malignant syndrome with trifluperidol. Br J Psychiatry. 1989 Oct;155:561-3. PubMed PMID: 2611583.
7: Marcucci F, Airoldi L, Mussini E, Garattini S. Distribution of haloperidol and trifluperidol in brain and blood of rats. Chem Biol Interact. 1972 May;4(6):427-30. PubMed PMID: 5030587.
8: Lewi PJ, Heykants JJ, Janssen PA. On the distribution and metabolism of neuroleptic drugs. 3. Pharmacokinetics of trifluperidol. Arzneimittelforschung. 1970 Nov;20(11):1701-5. PubMed PMID: 5536974.
9: Janssen PA, Allewijn FT. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity. Arzneimittelforschung. 1969 Feb;19(2):199-208. PubMed PMID: 5818759.
10: BISHOP MP, GALLANT DM. TRIFLUPERIDOL IN "PARANOID" AND "NON-PARANOID" SCHIZOPHRENICS. Curr Ther Res Clin Exp. 1965 Feb;7:96-101. PubMed PMID: 14260091.